AI assistant
MACROGENICS INC — Director's Dealing 2013
Oct 9, 2013
34129_dirs_2013-10-09_a05ed4de-7f9b-4be1-a5bb-71e966164d76.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2013-10-09
Reporting Person: Galbraith Kenneth (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series C Convertible Preferred Stock | $ | Common Stock (19724839) | Indirect | ||
| Series D-2 Convertible Preferred Stock | $ | Common Stock (3833767) | Indirect | ||
| Series D-2 Convertible Preferred Warrants | $ | Common Stock (287533) | Indirect |
Footnotes
F1: Each share of Series C Convertible Preferred Stock and each share of Series D-2 Convertible Preferred Stock is convertible into 0.0533 of a share of Common Stock without payment of further consideration and will automatically convert into 0.0533 of a share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
F2: These securities are held by Ventures West 8 Limited Partnership. Kenneth Galbraith is Managing Director of Five Corners Capital, Inc., the general partner of Ventures West 8 Limited Partnership . Kenneth Galbraith disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F3: Immediately.
F4: The warrants will expire upon the closing of the initial public offering.